Antiresorptive Therapy for the Prevention of Postmenopausal Osteoporosis: When Should Treatment Begin?

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.4, Iss.5, 2005-01, pp. : 263-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention and Treatment of Postmenopausal Osteoporosis

By Mahakala Aparna Thoutreddy Shalini Kleerekoper Michael

Treatments in Endocrinology, Vol. 2, Iss. 5, 2003-01 ,pp. : 331-345

Adis International

Access to resources Recommend Favorite

A more active role for gynecologists in the prevention of postmenopausal osteoporosis

By Ylikorkala Olavi

Gynecological Endocrinology, Vol. 24, Iss. 6, 2008-01 ,pp. : 293-294

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis

By Dane Cem Dane Banu Cetin Ahmet Erginbas Murat

Gynecological Endocrinology, Vol. 23, Iss. 7, 2007-07 ,pp. : 398-403

Informa Healthcare

Access to resources Recommend Favorite

Combining Bisphosphonates with Hormone Therapy for Postmenopausal Osteoporosis

By Fadanelli Margaret E.

Treatments in Endocrinology, Vol. 3, Iss. 6, 2004-01 ,pp. : 361-369

Adis International

Access to resources Recommend Favorite

Salmon Calcitonin in the Prevention and Treatment of Osteoporosis

By Avioli L.V.

Trends in Endocrinology and Metabolism, Vol. 8, Iss. 3, 1997-04 ,pp. : 89-92

Elsevier

Access to resources Recommend Favorite